Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Transplantation. 2011 Feb 27;91(4):479-86. doi: 10.1097/TP.0b013e3182066275.
Liver transplantation offers life-saving therapy for patients with decompensated liver disease or T2 hepatocellular carcinomas. In the United States, deceased donor livers are primarily allocated by Model for End-Stage Liver Disease (MELD) score within each of the country's more than 50 donation service areas (DSAs). Variation in DSA size, population, and organ availability have engendered concern that unequal access to deceased donor livers across DSAs contributes to geographic variability in outcome.
To determine the extent to which DSA variability in organ availability correlated with combined waitlist and posttransplant mortality, we analyzed retrospectively national waitlist and posttransplant data for a 7-year period after implementation of the current MELD-based allocation system.
Marked variation among DSAs was evident in death rate (3.3-fold), transplant rate (20-fold), and mean transplant MELD (>10 points). Death rate correlated with organ availability was assessed by transplant rate and transplant MELD. DSAs with low organ availability included the country's largest cities, had more new listings per capita, larger waitlists, more transplant centers per DSA, and a higher proportion of black and Asian patients. DSAs of organ shortage were also characterized by more frequent dual listing at another transplant center, more living donor liver transplants, and increased average length of the transplant admission.
Geographic differences in deceased donor organ availability contribute to variation in overall death rate of liver transplant patients, shape the clinical practice of transplant, and influence the resources consumed per transplant. Geographic variation in organ access results primarily from rates of listing rather than donation. Our findings highlight the need to restructure organ distribution areas to achieve equal access to deceased donor livers for transplantation in the United States.
肝移植为失代偿性肝病或 T2 肝细胞癌患者提供了挽救生命的治疗方法。在美国,超过 50 个供体服务区域(DSA)中的每个区域都主要根据模型预测终末期肝病评分(MELD)分配已故供体的肝脏。DSA 大小、人口和器官可用性的差异引起了人们的关注,即 DSAs 之间对已故供体肝脏的获取不平等可能导致结果的地理差异。
为了确定器官可用性的 DSA 变异性与联合等候名单和移植后死亡率之间的相关性程度,我们回顾性地分析了当前基于 MELD 的分配系统实施后 7 年的全国等候名单和移植后数据。
DSA 之间明显存在死亡率(3.3 倍)、移植率(20 倍)和平均移植 MELD(超过 10 分)的差异。通过移植率和移植 MELD 评估死亡率与器官可用性的相关性。器官可用性低的 DSA 包括该国最大的城市,人均新登记人数更多,等候名单更大,DSA 内的移植中心更多,黑人和亚洲患者的比例更高。器官短缺的 DSA 还具有以下特征:在另一个移植中心更频繁地双重登记、更多的活体供肝移植以及平均移植住院时间延长。
已故供体器官可用性的地理差异导致肝移植患者总体死亡率的变化,塑造了移植的临床实践,并影响了每例移植的资源消耗。器官获取的地理差异主要源于登记率而不是捐赠率。我们的发现强调需要重新构建器官分配区域,以在美国实现平等获取已故供体肝脏进行移植。